Visuals
Sidebar
Vaccination rates vary by county, determined by local factors
COVID-19 has disproportionately affected certain underserved and high-risk populations, including people of color, those with underlying health conditions, and those ...
Mapping global oxygen shortages
Despite using oxygen medically for over 100 years and WHO classifying it as an essential medicine in 2017, large population ...
Vaccine Passports: what we need to know
The COVID-19 pandemic has killed more than half a million people in the US and has seriously impacted our daily ...
Mapping the 8 most prominent strains of COVID-19
At least eight strains of the coronavirus are making their way around the globe, creating a trail of death and ...
Modeling the effectiveness of social restrictions
The isolation of symptomatic cases and tracing of contacts has been used as an early COVID-19 containment measure in many ...
Studying mutations in the Angiotensin-converting enzyme 2 (ACE2) to predict mutation pathways in SARS-CoV-2 variants
Interdisciplinary Research Center HALOmem collected information regarding naturally-occurring variants of the Angiotensin-converting enzyme 2 (ACE2), an epithelial receptor that both ...
Identifying signals for a fourth wave in the United States
Following weeks of good news about diminishing case counts, CDC Director Rochelle P. Walensky, MD, MPH, said in a White ...
Research publication trends during COVID-19
At first, COVID-19 papers (and preprints) focused on the spread of disease, the outcomes for people hospitalized, and diagnostics and ...
Tracking America’s vaccine rollout
Bloomberg has been tracking America's Covid-19 vaccine rollout, stating that an average of 1.7 million doses are being recorded every day. As of ...
American debt to exceed GDP in 2021
The United States is projected to hold about $21 trillion in debt in 2021, and that number is expected to ...
Heatmaps showing opioid sub-epidemics by demography and urbanicity
Total number of deaths in each category from 1999 through 2016 are shown in the upper left corner of each ...
Nations Pay Wildly Different Prices For Vaccines
In an ideal world, the price of a vial of vaccine would be consistent across the globe. But at this ...
BIIB080 in Mild Alzheimer’s Disease: What a Phase 1b Exploratory Clinical Analysis Can—and Cannot—Tell Us
Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...
Read morePopular
-
The Information Epidemic: How Digital Health Misinformation Is Rewiring Clinical Risk
-
Child Health Is Now a Platform Issue
-
Prevention Is Having a Moment and a Measurement Problem
-
Behavioral Health Is Now a Network Phenomenon
-
The Breach Is the Diagnosis: Cybersecurity Has Become a Clinical Risk Variable
